vs
Side-by-side financial comparison of Edwards Lifesciences (EW) and Welltower (WELL). Click either name above to swap in a different company.
Welltower is the larger business by last-quarter revenue ($2.8B vs $1.6B, roughly 1.7× Edwards Lifesciences). Welltower runs the higher net margin — 51.6% vs 23.1%, a 28.5% gap on every dollar of revenue. On growth, Welltower posted the faster year-over-year revenue change (180.6% vs 16.7%). Over the past eight quarters, Welltower's revenue compounded faster (42.4% CAGR vs 9.7%).
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the Sapien transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter.
Welltower Inc. is a real estate investment trust that invests in healthcare infrastructure. As of December 31, 2022, the company had investments in approximately 3,000 properties, all of which were in the United States, Canada, and the United Kingdom.
EW vs WELL — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.6B | $2.8B |
| Net Profit | $380.7M | $1.5B |
| Gross Margin | 78.0% | — |
| Operating Margin | 1.8% | — |
| Net Margin | 23.1% | 51.6% |
| Revenue YoY | 16.7% | 180.6% |
| Net Profit YoY | 6.8% | 93.7% |
| EPS (diluted) | $0.66 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.6B | $2.8B | ||
| Q4 25 | $1.6B | $2.6B | ||
| Q3 25 | $1.6B | $2.1B | ||
| Q2 25 | $1.5B | $2.0B | ||
| Q1 25 | $1.4B | $1.9B | ||
| Q4 24 | $1.4B | $1.8B | ||
| Q3 24 | $1.4B | $1.5B | ||
| Q2 24 | $1.4B | $1.4B |
| Q1 26 | $380.7M | $1.5B | ||
| Q4 25 | $91.2M | $117.8M | ||
| Q3 25 | $291.1M | $282.2M | ||
| Q2 25 | $333.2M | $304.6M | ||
| Q1 25 | $358.0M | $257.3M | ||
| Q4 24 | $385.6M | $123.8M | ||
| Q3 24 | $3.1B | $456.8M | ||
| Q2 24 | $366.3M | $260.7M |
| Q1 26 | 78.0% | — | ||
| Q4 25 | 78.1% | 24.3% | ||
| Q3 25 | 77.8% | 23.5% | ||
| Q2 25 | 77.5% | 23.2% | ||
| Q1 25 | 78.7% | 21.6% | ||
| Q4 24 | 78.9% | 20.0% | ||
| Q3 24 | 80.6% | 19.8% | ||
| Q2 24 | 79.9% | 20.2% |
| Q1 26 | 1.8% | — | ||
| Q4 25 | 9.6% | — | ||
| Q3 25 | 19.8% | 14.2% | ||
| Q2 25 | 26.8% | 15.1% | ||
| Q1 25 | 27.9% | 10.7% | ||
| Q4 24 | 22.6% | 6.2% | ||
| Q3 24 | 25.9% | 12.2% | ||
| Q2 24 | 26.8% | 6.5% |
| Q1 26 | 23.1% | 51.6% | ||
| Q4 25 | 5.8% | 4.6% | ||
| Q3 25 | 18.7% | 13.7% | ||
| Q2 25 | 21.7% | 15.5% | ||
| Q1 25 | 25.3% | 13.8% | ||
| Q4 24 | 27.8% | 7.0% | ||
| Q3 24 | 226.7% | 30.2% | ||
| Q2 24 | 26.7% | 18.7% |
| Q1 26 | $0.66 | — | ||
| Q4 25 | $0.16 | $0.13 | ||
| Q3 25 | $0.50 | $0.41 | ||
| Q2 25 | $0.56 | $0.45 | ||
| Q1 25 | $0.61 | $0.40 | ||
| Q4 24 | $0.65 | $0.20 | ||
| Q3 24 | $5.13 | $0.73 | ||
| Q2 24 | $0.61 | $0.42 |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EW
Segment breakdown not available.
WELL
| Resident fees and services | $1.9B | 67% |
| Other | $822.6M | 29% |
| Rental income | $103.4M | 4% |
